Noticias de EBS_US

Noticias del mercado

Últimas noticias sobre EBS_US — 240 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: EBS_US ✕ 240 resultados
27/02/2026 EBS_US — Yahoo Finance
Emergent Biosolutions Q4 Earnings Call Highlights
27/02/2026 EBS_US — DirectorsTalk Interviews
Emergent BioSolutions Inc. (EBS): Investor Outlook Reveals 21.62% Potential Upside Amidst Challenging Revenue Growth
27/02/2026 EBS_US — Stocktwits
Why Did Emergent Biosolutions Stock Tumble 20% After-Hours Today?
26/02/2026 EBS_US — MSN
Emergent BioSolutions authorizes $50 million stock repurchase program
26/02/2026 EBS_US — MSN
Emergent BioSolutions authorizes $50 million stock repurchase program
26/02/2026 EBS_US — Seeking Alpha
Emergent BioSolutions Inc. 2025 Q4 - Results - Earnings Call Presentation (NYSE:EBS) 2026-02-26
26/02/2026 EBS_US — Stock Titan
Naloxone maker Emergent BioSolutions posts $52.6M profit after $190.6M loss
26/02/2026 EBS_US — Yahoo Finance
Emergent BioSolutions Announces New $50 Million Stock Repurchase Program
26/02/2026 EBS_US — TipRanks
Emergent BioSolutions Reports Profitability Amid Ongoing Turnaround
26/02/2026 EBS_US — Investing.com
Emergent BioSolutions Q4 2025 slides: transformation advances despite revenue miss
26/02/2026 EBS_US — Investing.com
Earnings call transcript: Emergent Biosolutions Misses Q4 2025 Expectations, Stock Edges Up
26/02/2026 EBS_US — Stock Titan
Canada spends $140M to stockpile drugs for biological threats
26/02/2026 EBS_US — Stock Titan
Emergent BioSolutions lines up $50M for stock buybacks through 2027
26/02/2026 EBS_US — Investing.com
Emergent BioSolutions Q4 2025 slides: transformation advances despite revenue miss
26/02/2026 EBS_US — Investing.com
Emergent BioSolutions authorizes $50M stock buyback program
26/02/2026 EBS_US — GlobeNewswire
Emergent BioSolutions Announces Approximately $140 Million
26/02/2026 EBS_US — GuruFocus
Emergent BioSolutions (EBS) Projects Significant Growth in FY26 Earnings
26/02/2026 EBS_US — GuruFocus ES ← EN
Emergent BioSolutions (EBS) apunta a la expansión y el crecimiento global
20/02/2026 EBS_US — DirectorsTalk Interviews
Emergent BioSolutions Inc. (EBS) Stock Analysis: Navigating a 22.84% Potential Upside Amidst Healthcare Challenges
14/02/2026 EBS_US — Stock Titan
EBS Financials: Income Statement, Balance Sheet & Cash Flow | Emergent Biosolutions Inc

Página 12 de 12

keyboard_arrow_up